ESSA Pharma Inc.
EPIX
$0.2456
-$0.0175-6.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.20% | 25.28% | -34.25% | 12.14% | 19.53% |
| Total Depreciation and Amortization | -31.67% | 2.56% | 2.63% | 0.44% | 2.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -161.95% | -59.23% | -8.90% | 28.37% | 73.34% |
| Change in Net Operating Assets | 126.97% | -273.51% | -237.68% | 146.88% | -165.37% |
| Cash from Operations | 38.67% | -5.85% | -92.21% | 41.41% | 15.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,597.99% | 96.08% | -118.69% | 89,365.53% | -99.96% |
| Cash from Investing | 2,597.99% | 96.08% | -118.69% | 89,365.53% | -99.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 133.20% | -96.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 133.20% | -96.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 442.11% | -146.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.92% | 32.66% | -158.67% | 411.07% | -110.11% |